 Dermatitis, Atopic
"Dermatitis, Atopic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Descriptor ID |
D003876
|
| MeSH Number(s) |
C16.320.850.210 C17.800.174.193 C17.800.815.193 C17.800.827.210 C20.543.480.343
|
| Concept/Terms |
Dermatitis, Atopic- Dermatitis, Atopic
- Atopic Dermatitides
- Atopic Dermatitis
- Dermatitides, Atopic
- Neurodermatitis, Atopic
- Atopic Neurodermatitides
- Atopic Neurodermatitis
- Neurodermatitides, Atopic
- Neurodermatitis, Disseminated
- Disseminated Neurodermatitides
- Disseminated Neurodermatitis
- Neurodermatitides, Disseminated
- Eczema, Atopic
- Atopic Eczema
|
Below are MeSH descriptors whose meaning is more general than "Dermatitis, Atopic".
- Diseases [C]
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16]
- Genetic Diseases, Inborn [C16.320]
- Skin Diseases, Genetic [C16.320.850]
- Dermatitis, Atopic [C16.320.850.210]
- Skin and Connective Tissue Diseases [C17]
- Skin Diseases [C17.800]
- Dermatitis [C17.800.174]
- Dermatitis, Atopic [C17.800.174.193]
- Skin Diseases, Eczematous [C17.800.815]
- Dermatitis, Atopic [C17.800.815.193]
- Skin Diseases, Genetic [C17.800.827]
- Dermatitis, Atopic [C17.800.827.210]
- Immune System Diseases [C20]
- Hypersensitivity [C20.543]
- Hypersensitivity, Immediate [C20.543.480]
- Dermatitis, Atopic [C20.543.480.343]
Below are MeSH descriptors whose meaning is more specific than "Dermatitis, Atopic".
This graph shows the total number of publications written about "Dermatitis, Atopic" by people in this website by year, and whether "Dermatitis, Atopic" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 | | 1995 | 2 | 0 | 2 | | 1996 | 2 | 0 | 2 | | 1997 | 1 | 0 | 1 | | 1998 | 5 | 0 | 5 | | 1999 | 2 | 0 | 2 | | 2000 | 3 | 1 | 4 | | 2001 | 2 | 1 | 3 | | 2002 | 4 | 0 | 4 | | 2003 | 10 | 2 | 12 | | 2004 | 6 | 1 | 7 | | 2005 | 7 | 1 | 8 | | 2006 | 12 | 2 | 14 | | 2007 | 4 | 1 | 5 | | 2008 | 13 | 0 | 13 | | 2009 | 4 | 1 | 5 | | 2010 | 15 | 2 | 17 | | 2011 | 7 | 0 | 7 | | 2012 | 6 | 2 | 8 | | 2013 | 5 | 2 | 7 | | 2014 | 8 | 1 | 9 | | 2015 | 6 | 0 | 6 | | 2016 | 8 | 1 | 9 | | 2017 | 11 | 1 | 12 | | 2018 | 19 | 1 | 20 | | 2019 | 18 | 2 | 20 | | 2020 | 15 | 0 | 15 | | 2021 | 14 | 1 | 15 | | 2022 | 17 | 0 | 17 | | 2023 | 17 | 0 | 17 | | 2024 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Dermatitis, Atopic" by people in Profiles.
-
Eichenfield LF, Silverberg JI, Hebert AA, Boguniewicz M. Targeting the aryl hydrocarbon receptor as a strategy to expand the therapeutic armamentarium in atopic dermatitis. J Dermatolog Treat. 2024 Dec; 35(1):2300354.
-
Silverberg JI, Boguniewicz M, Quintana FJ, Clark RA, Gross L, Hirano I, Tallman AM, Brown PM, Fredericks D, Rubenstein DS, McHale KA. Tapinarof validates the aryl hydrocarbon receptor as a therapeutic target: A?clinical review. J Allergy Clin Immunol. 2024 Jul; 154(1):1-10.
-
Chu DK, Schneider L, Asiniwasis RN, Boguniewicz M, De Benedetto A, Ellison K, Frazier WT, Greenhawt M, Huynh J, Kim E, LeBovidge J, Lind ML, Lio P, Martin SA, O'Brien M, Ong PY, Silverberg JI, Spergel JM, Wang J, Wheeler KE, Guyatt GH, Capozza K, Begolka WS, Chu AWL, Zhao IX, Chen L, Oykhman P, Bakaa L, Golden D, Shaker M, Bernstein JA, Greenhawt M, Horner CC, Lieberman J, Stukus D, Rank MA, Wang J, Ellis A, Abrams E, Ledford D, Chu DK. Atopic dermatitis (eczema) guidelines: 2023 American Academy of Allergy, Asthma and Immunology/American College of Allergy, Asthma and Immunology Joint Task Force on Practice Parameters GRADE- and Institute of Medicine-based recommendations. Ann Allergy Asthma Immunol. 2024 03; 132(3):274-312.
-
Chu DK, Chu AWL, Rayner DG, Guyatt GH, Yepes-Nu?ez JJ, Gomez-Escobar L, P?rez-Herrera LC, D?az Martinez JP, Brignardello-Petersen R, Sadeghirad B, Wong MM, Ceccacci R, Zhao IX, Basmaji J, MacDonald M, Chu X, Islam N, Gao Y, Izcovich A, Asiniwasis RN, Boguniewicz M, De Benedetto A, Capozza K, Chen L, Ellison K, Frazier WT, Greenhawt M, Huynh J, LeBovidge J, Lio PA, Martin SA, O'Brien M, Ong PY, Silverberg JI, Spergel JM, Smith Begolka W, Wang J, Wheeler KE, Gardner DD, Schneider L. Topical treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials. J Allergy Clin Immunol. 2023 12; 152(6):1493-1519.
-
Chu AWL, Wong MM, Rayner DG, Guyatt GH, D?az Martinez JP, Ceccacci R, Zhao IX, McMullen E, Srivastava A, Wang J, Wen A, Wang FC, Brignardello-Petersen R, Izcovich A, Oykhman P, Wheeler KE, Wang J, Spergel JM, Singh JA, Silverberg JI, Ong PY, O'Brien M, Martin SA, Lio PA, Lind ML, LeBovidge J, Kim E, Huynh J, Greenhawt M, Gardner DD, Frazier WT, Ellison K, Chen L, Capozza K, De Benedetto A, Boguniewicz M, Smith Begolka W, Asiniwasis RN, Schneider LC, Chu DK. Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials. J Allergy Clin Immunol. 2023 12; 152(6):1470-1492.
-
Guttman-Yassky E, Irvine AD, Brunner PM, Kim BS, Boguniewicz M, Parmentier J, Platt AM, Kabashima K. The role of Janus kinase signaling in the pathology of atopic dermatitis. J Allergy Clin Immunol. 2023 12; 152(6):1394-1404.
-
Simpson EL, Guttman-Yassky E, Eichenfield LF, Boguniewicz M, Bieber T, Schneider S, Guana A, Silverberg JI. Tralokinumab therapy for moderate-to-severe atopic dermatitis: Clinical outcomes with targeted IL-13 inhibition. Allergy. 2023 11; 78(11):2875-2891.
-
Siegfried EC, Arkin LM, Chiu YE, Hebert AA, Callen JP, Castelo-Soccio L, Co DO, Cordoro KM, Curran ML, Dalrymple AM, Flohr C, Gordon KB, Hanna D, Irvine AD, Kim S, Kirkorian AY, Lara-Corrales I, Lindstrom J, Paller AS, Reyes M, Begolka WS, Tom WL, Van Voorhees AS, Vleugels RA, Lee LW, Davies OMT, Brandling-Bennett HA. Methotrexate for inflammatory skin disease in pediatric patients: Consensus treatment guidelines. Pediatr Dermatol. 2023 Sep-Oct; 40(5):789-808.
-
Simpson EL, Schlievert PM, Yoshida T, Lussier S, Boguniewicz M, Hata T, Fuxench Z, De Benedetto A, Ong PY, Ko J, Calatroni A, Rudman Spergel AK, Plaut M, Quataert SA, Kilgore SH, Peterson L, Gill AL, David G, Mosmann T, Gill SR, Leung DYM, Beck LA. Rapid reduction in Staphylococcus aureus in atopic dermatitis subjects following dupilumab treatment. J Allergy Clin Immunol. 2023 11; 152(5):1179-1195.
-
Simpson EL, De Benedetto A, Boguniewicz M, Ong PY, Lussier S, Villarreal M, Schneider LC, Paller AS, Guttman-Yassky E, Hanifin JM, Spergel JM, Barnes KC, David G, Austin B, Leung DYM, Beck LA. Phenotypic and Endotypic Determinants of Atopic Dermatitis Severity From the Atopic Dermatitis Research Network (ADRN) Registry. J Allergy Clin Immunol Pract. 2023 08; 11(8):2504-2515.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|